CJC-1295 · Ipamorelin

Growth Hormone · 10 mg fill · Research Peptide

A no-DAC GHRH analog paired with a selective secretagogue, investigated for endogenous GH rhythm.

Overview

This research blend combines CJC-1295 in its no-DAC (modified GRF 1–29) short-acting form with Ipamorelin, a selective growth-hormone secretagogue. The pairing is studied in models of pulsatile growth-hormone release and somatotropic-axis signaling.

Specifications

Composition

CJC-1295 no-DAC (mod. GRF 1–29) 5 mg + Ipamorelin 5 mg

Form

Lyophilized blend

Vial Size

10 mg (combined)

Purity

>99% (HPLC, per component)

Reconstitution

Bacteriostatic water

Storage

−20°C · protect from light

Documentation

Batch-specific COA

Research applications

• Pulsatile GH-release research
• Somatotropic-axis signaling models
• Combination-peptide synergy studies
• Receptor-selectivity research

For research use only. This product is intended for laboratory and educational research purposes only. It has not been evaluated by the FDA and is not for human or veterinary consumption, diagnosis, treatment, or cure of any condition.

Ordering, vial options and the cart live in the catalog view.